Or Eisenberg insider trades
Open-market stock purchases and sales by Or Eisenberg, Chief Financial Officer at NeuroSense Therapeutics Ltd, from SEC Form 4 filings since Apr 4, 2018.
Open-market stock purchases and sales by Or Eisenberg, Chief Financial Officer at NeuroSense Therapeutics Ltd, from SEC Form 4 filings since Apr 4, 2018.